About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: April 19, 2010
DDMAC Erupts – A Troika of DDMAC Regulatory Action Letters
(NOTE: After the initial publication of this posting, information was sent to me regarding FDA's Guidance on Risk Information – the posting was changed to note this important update and re-published. The change is noted in italics in the third … Continue reading
Posted in Warning Letters
2 Comments